TRIAZOLE DERIVATIVES AS HSP90 INHIBITORS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150051203A1
SERIAL NO

14387715

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A compound of structural formula (I) or (II): as HSP90 inhibitors that possess significantly improved bioavailability over comparative compounds, which are suitable for the treatment of hyperproliferative diseases such as cancer, infections, immune disorders, inflammation, and CNS related disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SYNTA PHARMACEUTICALS CORP45 HARTWELL AVENUE LEXINGTON MA 02421

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chimmanamada, Dinesh Arlington, US 17 485
Demko, Zachary Los Altos Hills, US 166 9079
Ying, Weiwen Lexington, US 100 1571

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation